Warp I wrestled with the AS increase and went back

Warp I wrestled with the AS increase and went back and forth for a long long time - ultimately though, my wife and I voted no. Needless to say, we need to get the pps much much higher before a RS and planned uplisting. I'm just not sure why they have not signed a BP on a LymPro JV Agreement - unless it will detract from the inherent value created by a proposed Daig. Div. spin off. I truly hope Gerald has the catalyst to get us well above $0.25 or. $0.35 before a RS. But with 800-mil. out on the Street now, I'm not certain we will make it. We would have to churn the float a minimum of 3 to 5 times to get us in that neighborhood - and that would be an absolute "moon shot" from where we presently sit. It's almost impossible to get the horses back in the starting gate once their out, and I have been on Gerald and Mark repeatedly about serial dilution. Living off the SEDA is one thing, but diluting into the float at the same time utilizing SEDA funding is IMHO, double jeapordy for the shareholders. I am more concerned about the safety of my investment now than ever before due to the erosion factor - and I will consider an exit provided we do not pull revenue in the near term. Understand, I've been down the dilution road before in OTC and it slowly suffocates all shareholders - except the Owners, who can withstand the subsequent loss in equity.